Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Surface Oncology, Inc. (SURF)  
$1.07 0.00 (0.00%) as of 4:30 Thu 9/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 54,611,000
Market Cap: 58.43(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.58 - $1.08
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Surface Oncology is an immuno-oncology company focused on using its knowledge of the biological pathways crucial to the immunosuppressive tumor microenvironment (TME) for the development of cancer therapies. NZV930 and SRF617 are antibodies inhibiting cluster of differentiation (CD) 73 and CD39, respectively, and illustrate how Co.'s knowledge of TME biology can be utilized across programs. SRF388 is an antibody targeting interleukin 27, an immunosuppressive cytokine, or protein that is overexpressed in certain cancers, including hepatocellular, lung and renal cell carcinoma. GSK4381562 is an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 37,090 68,266
Total Sell Value $0 $0 $34,864 $88,487
Total People Sold 0 0 4 6
Total Sell Transactions 0 0 4 9
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 102
  Page 2 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Goater Jeff Director   –       •      –    2021-07-21 4 S $6.10 $779,446 D/D (127,778) 129,222 15%     
   Nogelo Liisa I Chief Legal Officer   •       –      –    2021-07-21 4 S $6.10 $160,583 D/D (26,325) 53,675 15%     
   Palombella Vito J. Chief Scientific Officer   •       –      –    2021-07-21 4 S $6.10 $160,583 D/D (26,325) 53,675 15%     
   Fees Jessica Chief Financial Officer   •       –      –    2021-07-21 4 S $6.10 $121,109 D/D (19,854) 79,329 15%     
   Ross Robert W. Chief Executive Officer   •       –      –    2021-07-21 4 S $6.10 $204,350 D/D (33,500) 54,500 15%     
   Goater Jeff Director   –       •      –    2021-06-11 4 S $7.61 $116,226 D/D (15,273) 257,000 -2%     
   Goater Jeff Director   –       •      –    2021-06-11 4 OE $4.14 $42,530 D/D 10,273 272,273     -
   Goater Jeff Director   –       •      –    2021-06-10 4 S $7.66 $1,798,619 D/D (234,727) 262,000 2%     
   Goater Jeff Director   –       •      –    2021-06-10 4 OE $4.14 $971,770 D/D 234,727 496,727     -
   Ross Robert W. Chief Medical Officer   •       –      –    2021-02-16 4 AS $11.35 $11,350 D/D (1,000) 88,000 -32%     
   Goater Jeff Chief Executive Officer   •       •      –    2021-02-08 4 AS $12.50 $31,250 D/D (2,500) 262,000 -42%     
   Goater Jeff Chief Executive Officer   •       •      –    2021-02-08 4 OE $3.18 $7,950 D/D 2,500 264,500     -
   Fees Jessica See Remarks   •       –      –    2021-02-08 4 AS $12.45 $18,675 D/D (1,500) 99,183 -42%     
   Fees Jessica See Remarks   •       –      –    2021-02-01 4 AS $11.19 $16,785 D/D (1,500) 100,683 -31%     
   Goater Jeff Chief Executive Officer   •       •      –    2021-02-01 4 AS $10.69 $26,718 D/D (2,500) 262,000 -31%     
   Goater Jeff Chief Executive Officer   •       •      –    2021-02-01 4 OE $3.18 $7,950 D/D 2,500 264,500     -
   Goater Jeff Chief Executive Officer   •       •      –    2021-01-19 4 AS $13.00 $65,000 D/D (5,000) 262,000 -33%     
   Goater Jeff Chief Executive Officer   •       •      –    2021-01-19 4 OE $3.18 $15,900 D/D 5,000 267,000     -
   Ross Robert W. Chief Medical Officer   •       –      –    2021-01-15 4 AS $12.25 $24,500 D/D (2,000) 89,000 -30%     
   Ross Robert W. Chief Medical Officer   •       –      –    2021-01-14 4 AS $11.95 $83,650 D/D (7,000) 91,000 -28%     
   Atlas Venture Associates Ix, Llc 10% Owner   –       –       •   2020-12-17 4 S $18.10 $30,770,000 D/D (1,700,000) 2,945,453 15%     
   Grayzel David S. Director   –       •      –    2020-12-17 4 S $18.10 $30,770,000 I/I (1,700,000) 2,945,453 15%     
   Ross Robert W. Chief Medical Officer   •       –      –    2020-12-15 4 AS $10.48 $10,480 D/D (1,000) 98,000 -27%     
   Ross Robert W. Chief Medical Officer   •       –      –    2020-12-11 4 AS $10.05 $14,120 D/D (1,405) 99,000 -26%     
   Fees Jessica See Remarks   •       –      –    2020-11-25 4 OE $4.14 $6,996 D/D 1,383 102,183     -
  102 Records found
  1  2  3  4  5   
  Page 2 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us